Autoreactive T cells in murine lupus: Origins ond roles in autoantibody production

Immunologic Research

Volumn 19, Issue 2-3, 1999, Pages 245-257

  Craft, Joe ^a   Peng, Stanford ^a,b   Fujii, Takao ^a   Okada, Masato ^a   Fatenejad, Saeed ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Autoantibodies; Autoimmunity; Lupus; Mouse models; MRL mice; T lymphocytes

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN;

ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNITY; B LYMPHOCYTE; MOUSE; NONHUMAN; PENETRANCE; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 0032797012     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786492     Document Type: Review

References (85)

1. Tan EM: Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151.
2. Theofilopoulos AN, Dixon FJ: Murine models of systemic lupus erythematosus. Adv Immunol 1985;37:269-390.
3. Eisenberg RA, Tan EM, Dixon FJ: Presence of anti-Sm reactivity in autoimmune mouse strains. J Exp Med 1978;147:582-587.
4. Hewicker M, Trautwein G: Glomerular lesions in MRL mice. A light and immunofluorescence microscopic study. Zentralblatt für Veterinarmedizin Reihe B 1986;33:727-739.
5. Burlingame RW, Rubin RL, Balderas RS, Theofilopoulos AN: Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest 1993;91:1687-1696.
6. Fatenejad S, Brooks W, Schwartz A, Craft J: Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmuno genic target. J Immunol 1994;152;5523-5531.
7. Rathmell JC, Goodnow CC: Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. J Immunol 1994;153:2831-2842.
8. Singer GG, Abbas AK: The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994;1:365-371.
9. Van Parijs L, Ibraghimov A, Abbas AK: The roles of costimulation and fas in T cell apoptosis and peripheral tolerance. Immunity 1996;4:321-328.
10. Izui S, Kelley VE, Masuda K, Yoshida H, Roths JB, Murphy ED: Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol 1984;133:227-233.
11. Peng SL, Craft J: The regulation of murine lupus. Ann NY Acad Sci 1997;815:128-138.
12. Craft J, Fatenejad S: Self antigens and epitope spreading in systemic autoimmunity. Arthritis Rheum 1997;40:1374-1382.
13. Hardin JA:The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 1986;29:457-460.
14. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL, Weigert MG: The role of clonal selection and somatic mutation in autoimmunity. Nature 1987;328:805-811.
15. Eilat D, Webster DM, Rees AR: V region sequences of anti-DNA and anti-RNA autoantibodies from NZB/NZW F1 mice. J Immunol 1988;141:1745-1743.
16. Shlomchik MJ, Mascelli M, Shan H, Radic MZ, Pisetsky D, Marshak-Rothstein A, et al.: Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 1990;171:265-273.
17. Marion TN, Tillman DM, Jou N: Interclonal and intraclonal diversity among anti-DNA antibodies from an (NZB × NZW)F1 mouse. J Immunol 1990;145:2322-2332.
18. O'Keefe TL, Bandyopadhyay S, Datta SK, Imanishi-Kari T:Vregion sequences of an idiotypically con nected family of pathogenic anti-DNA autoantibodies. J Immunol 1990;144:4275-4283.
19. Davidson A, Mannheimer-Lory A, Aranow C, Peterson R, Hannigan N, Diamond B: Molecular characterization of a somatically mutated anti-DNA antibody bearing two SLE related idiotypes. J Clin Invest 1990;85:1401-1409.
20. Diamond B, Katz JB, Paul E, Aranow C, Lustgarten D, Scharff MD: The role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol 1992;10:731-757.
21. Radic MZ, Weigert M: Genetic and structural evidence for antigen selection of anti-DNA anti bodies. Annu Rev Immunol 1994;12:487-520.
22. Steinberg AD, Roths JB, Murphy ED, Steinberg RT, Raveche ES: Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J Immunol 1980;125:871-873.
23. Wofsy DL, Ledbetter JA, Hendler PL, Seaman WE: Treatment of murine lupus with monoclonal anti-T cell antibody. J Immunol 1985;134:852.
24. Santoro TJ, Portanova JP, Kotzin BL: The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J Exp Med 1988;167:1713-1718.
25. Sobel ES, Cohen PL, Eisenberg RA: lpr T cells are necessary for autoantibody production in lpr mice. J Immunol 1993;150:4160-4167.
26. Philpott KL, Viney JL, Kay G, Rastan S, Gardiner EM, Chae S, et al.: Lymphoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells. Science 1992;256:1448-1452.
27. Peng SL, Madaio MP, Hughes DPM, Crispe I, Owen M, Wen L, Hayday A, Craft J: Murine lupus in the absence of αβ T cells. J Immunol 1996;156:4041-4049.
28. Jevnikar AM, Grusby MJ, Glimcher LH: Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med 1994;179:1137-1143.
29. Koh D-R, Ho A, Rahemutulla A, Fung-Leung W-P, Griesser H, Mak T-W: Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur J Immunol 1995;25:2558-2562.
30. Giese T, Davidson WF: Chronic treatment of C3H-lpr/lpr and C3H-gId/gId mice with anti-CD8 monoclonal antibody prevent the accumulation of double negative T cells but not autoantibody production. J Immunol 1994;152:2000.
31. Giese T, Davidson WF: CD8+ T cell-deficient lpr/lpr mice, CD4+ B220+ and CD4+B220. T cells replace B220+double-negative T cells as the predominant populations in enlarged lymph nodes. J Immunol 1995;154: 4986-4995.
32. Maldonado MA, Eisenberg RA, Roper E, Cohen PL, Kotzin BL: Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I J Exp Med 1995;181:641-648.
33. 2-microglobulin. J Immunol 1995;154:2063-2074.
34. + T cells but normal autoantibody production in lpr/lpr mice lacking major histocompatibility complex class I molecules. Eur J Immunol 1995;25:37-41.
35. Adams S, Leblanc P, Datta SK: Junctional region sequences of T-cell receptor beta-chain genes expressed by pathogenic anti-DNA autoantibody-inducing helper T cells from lupus mice: possible selection by cationic autoantigens. PNAS 1991;88:11,271-11,275.
36. Mohan C, Adams S, Stanik V, Datta SK: Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993;177:1367-1381.
37. Kaliyaperumal A, Mohan C, Wu W, Datta SK: Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J Exp Med 1996;183:2459-2469.
38. Sobel ES, Kakkanaiah VN, Kakkanaiah M, Cheek RL, Cohen PL, Eisenberg RA: T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted. J Immunol 1994;152:6011-6016.
39. Ma J, Xu J, Peng Q, Zhang J, Grewal IS, Flavell RA, Craft J: Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous immunoglobulin class switching with dichotomy of autoantibody responses. J Immunol 1996;157:417-426.
40. Finck BK, Linsley PS, Wofsy D: Treatment of murine lupus with CTLA4Ig. Science 1994;265:1225-1227.
41. Mohan C, Shi Y, Laman JD, Datta SK: Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 1995;154:1470-1480.
42. Kaye J, Hsu ML, Sauron ME, Jameson SC, Gascoigne NR, Hedrick SM: Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature 1989;341:746-749.
43. Peng SL, Patenejad S, Craft J: Induction of non-pathologic, humoral autoimmunity in lupus-prone mice by a class II-restricted, transgenic αβ T cell: separation of autoantigen-specific and -nonspecific help. J Immunol 1996;157:5225-5230.
44. Desai-Mehta A, Lu L, Ramsey GR, Datta SK: Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996;97:2063-2073.
45. Desai-Mehta A, Mao C, Rajagopalan S, Robinson T, Datta SK; Structure and specificity of T cell receptors expressedby potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest 1995;95:531-541.
46. Koshy M, Berger D, Crow MK: Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 1996;98:826-837.
47. Hoffman RW, Takeda Y, Sharp GC, Lee DR, Hill DL, Kaneoka H, et al.: Human T cell clones reactive against U-small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals. J Immunol 1993;151:6460.
48. Okubo M, Yamamoto K, Kato T, Matsuuraa N, Nishimaki T, Kasukawa R, et al.: Detection and epitope analysis of autoantigen-reactive T cells to the U1-small nuclear ribonucleoprotein A protein in autoimmune disease patients. J Immunol 1993;151:1108-1115.
49. Eisenberg R, Dyer K, Craven SY, Fuller CR, Yount W: Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm. J Clin Invest 1985;75:1270.
50. Crow MK, DelGiudice-Asch G, Zehetbauer JB, Lawson JL, Brot N, Weissbach H, et al.: Autoantigen-specific T cell proliferation induced by the ribosomal P2 protein in patients with systemic lupus erythematosus. J Clin Invest 1994;94:345.
51. Zhou T, Bluethmann H, Zhang J, Edwards CK III, Mountz JD: Defective maintenance of T cell tolerance to a superantigen in MRL-lpr/lpr mice. J Exp Med 1992;176:1063-1072.
52. Scott DE, Kisch WJ, Steinberg AD: Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice. J Immunol 1993;150:664-672.
53. Herron LR, Eisenberg RA, Roper E, Kakkanaiah VN, Cohen PL, Kotzin BL: Selection of the T cell receptor repertoire in lpr mice. J Immunol 1993;151:3450-3459.
54. Berg LJ, Fazekas de St. Groth B, Groth BF, Pullen AM, Davis MM: Phenotypic differences between aαβ versus β T-cell receptor transgenic mice undergoing negative selection. Nature 1989;340:559-562.
55. Bill J, Kanagawa O, Linten J, Utsunomiya Y, Palmer E: Class I and class II MHC gene products differentially affect the fate of Vb5 bearing thymocytes. J Mol Cell Immunol 1990;4:269-279.
56. Fink PJ, Swan K, Turk G, Moore MW, Carbone FR: Both intrathymic and peripheral selection modulate the differential expression of Vβ5 among CD4+ and CD8+ T cells. J Exp Med 1992;176:1733-1738.
57. Kisielow P, Bluthmann H, Staerz UD, Steinmetz M, von Boehmer H: Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 1988;333:742-746.
58. Sha WC, Nelson CA, Newberry RD, Kranz DM, Russell JH, Loh DY: Positive and negative selection of an antigen receptor on T cells in transgenie mice. Nature 1988;336:73-76.
59. Smyth L, Howell M, Crispe IN: Self-reactivity and the expression of memory markers vary independently in MRL-Mp+/+ and MRL-Mp-lpr/lpr mice. Dev Immunol 1992;2:309-318.
60. Castro JE, Listman JA, Jacobson BA, Wang Y, Lopez PA, Ju S, et al.: Fas modulation of apoptosis during negative selection of thymocytes. Immunity 1996;5:617-627.
61. Sytwu HK, Liblau RS, McDevitt HO:The roles of Fas/APO-1(CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 1996;5:17-30.
62. Singer GG, Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994;1:365-371.
63. Fatenejad S, Peng S, Disorbo O, Craft J: Central T cell tolerance in lupus-prone mice: Influence of autoimmune background and the lpr mutation. J Immunol 1998;161:6427-6432.
64. Kretz-Rommel A, Duncan SR, Ruhin RL: Autoimmunity caused by disruption of central T cell tolerance: A murine model of drug-induced lupus. J Clin Invest 1997;99:1888-1896.
65. Peng S, Cappadona J, McNiff J, Madaio M, Owen M, Hayday A, et al.: Pathogenesis of autoimmunity in αβ T cell-deficient lupus-prone mice. Clin Exp Immunol 1998;111:107-116.
66. Peng SL, McNiff JM, Madaio MP, Ma J, Owen M, Flavell RA, et al.: αβ T cell regulation and CD40 ligand dependence in murine systemic autoimmunity. J Immunol 1997;158:2464-2470.
67. Ferrick DA, Schrenzel MD, Mulvania T, Hsieh B, Ferlin WG, Lepper H: Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo. Nature 1995;373:255-257.
68. + T cells provide B cell help. J Exp Med 1992;175:695-707.
69. + T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4. J Immunol 1992;148;1674-1684.
70. McMenamin C, Pimm C, McKersey M, Holt PC: Regulation of IgE responses to inhaled antigen in mice by antigen-specific γδ T cells. Science 1994;265:1869-1871.
71. Wen L, Roberts SJ, Viney JL, Wong FS, Mallick C, Findly RC, et al.: Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in αβ(+) T cells. Nature 1994;369:654-658.
72. Horner AA, Jabara H, Ramesh N, Geha RS: γ/δ T lymphocytes express CD40 ligand and induce isotype switching in B lymphocytes. J Exp Med 1995;181:1239-1244.
73. Peterman GM, Spencer C, Sperling AI, Bluestone JA: Role of γδ T cells in murine collagen-induced arthritis. J Immunol 1993;151:6546-6558.
74. Maeda T, Saikawa I, Hotokebuchi T, Sugioka Y, Eto M, Murakami Y, et al.: Exacerbation of established collagen-induced arthritis in mice treated with an anti-T cell receptor antibody. Arthritis Rheum 1994;37:406-413.
75. Pelegrí C, Kühnlein P, Buchner E, Schmidt CB, Franch A, Castell M, et al.: Depletion of γ/δ T cells does not prevent or ameliorate, but rather aggravates, rat adjuvant arthritis. Arthritis Rheum 1996;39:204-215.
76. Thurau SR, Kühnlein P, Hünig T, Wildner G: The role of gamma-delta T cells in induction and suppression of autoimmune uveitis [Abstract]. Immunobiology 1995;194:157.
77. - T helper cell lines that express the γδ T-cell antigen receptor. PNAS 1990;87:7020-7024.
78. Dianda L, Gulbranson-Judge A, Pao W, Hayday AC, MacLennan ICM, Owen MJ: Germinal center formation in mice lacking αβ T cells. Eur J Immunol 1996;26: 1603-1607.
79. Peng SL, Madaio MP, Hayday AC, Craft J: Propagation and regulation of systemic autoimmunity by γδ T cells. J Immunol 1996;157:5689-5698.
80. Mizoguchi A, Mizoguchi E, Chiba C, Spiekermann GM, Tonegawa S, Nagler-Anderson C, et al.: Cytokine imbalance and autoantibody production in T cell receptor-α mutant mice with inflammatory bowel disease. J Exp Med 1996;183:847-856.
81. ;-/- mice. J Immunol 1995;154:1569-1576.
82. Klinman DM, Steinberg AD: Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 1987;165:1755-1760.
83. Abed NS, Chace JH, Cowdery JS: T cell-independent and T cell-dependent B cell activation increases IFN-γR expression and renders B cells sensitive to IFN-g-mediated inhibition. J Immunol 1994;153:3369-3377.
84. + T cells. Nature 1995;376:181-184.
85. Chan O, Shlomchik MJ: A new role of B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J Immunol 1998;160:51-59.